Celldex Therapeutics Inc (CLDX)
38.48
-1.15
(-2.90%)
USD |
NASDAQ |
Apr 18, 16:00
38.51
+0.03
(+0.08%)
After-Hours: 20:00
Celldex Therapeutics Cash from Investing (Quarterly): -171.16M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -171.16M |
| September 30, 2023 | 11.65M |
| June 30, 2023 | 1.164M |
| March 31, 2023 | 52.57M |
| December 31, 2022 | 31.21M |
| September 30, 2022 | 23.07M |
| June 30, 2022 | 25.28M |
| March 31, 2022 | 10.38M |
| December 31, 2021 | -18.94M |
| September 30, 2021 | -226.79M |
| June 30, 2021 | -13.91M |
| March 31, 2021 | 43.49M |
| December 31, 2020 | 30.85M |
| September 30, 2020 | -42.51M |
| June 30, 2020 | -108.53M |
| March 31, 2020 | 21.96M |
| December 31, 2019 | 3.224M |
| September 30, 2019 | 5.519M |
| June 30, 2019 | -7.959M |
| March 31, 2019 | 16.30M |
| December 31, 2018 | 3.348M |
| September 30, 2018 | -2.221M |
| June 30, 2018 | 13.19M |
| March 31, 2018 | 15.50M |
| December 31, 2017 | -13.38M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.665M |
| June 30, 2017 | 35.78M |
| March 31, 2017 | 22.40M |
| December 31, 2016 | 27.78M |
| September 30, 2016 | 14.92M |
| June 30, 2016 | 0.667M |
| March 31, 2016 | 25.54M |
| December 31, 2015 | 18.74M |
| September 30, 2015 | 12.26M |
| June 30, 2015 | -16.16M |
| March 31, 2015 | -65.04M |
| December 31, 2014 | 17.70M |
| September 30, 2014 | 18.02M |
| June 30, 2014 | 4.599M |
| March 31, 2014 | -81.33M |
| December 31, 2013 | -13.82M |
| September 30, 2013 | 5.558M |
| June 30, 2013 | -22.58M |
| March 31, 2013 | -46.58M |
| December 31, 2012 | -4.537M |
| September 30, 2012 | 5.987M |
| June 30, 2012 | 9.077M |
| March 31, 2012 | -27.51M |
| December 31, 2011 | 8.044M |
| September 30, 2011 | 10.35M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-226.79M
Minimum
Sep 2021
52.57M
Maximum
Mar 2023
-17.34M
Average
5.519M
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| ThermoGenesis Holdings Inc | -0.192M |
| Perspective Therapeutics Inc | -0.089M |
| Electromed Inc | -0.087M |
| Xtant Medical Holdings Inc | -2.313M |
| Asensus Surgical Inc | 7.427M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.53M |
| Cash from Financing (Quarterly) | 217.37M |
| Free Cash Flow | -109.11M |
| Free Cash Flow Per Share (Quarterly) | -0.6376 |
| Free Cash Flow to Equity (Quarterly) | -33.20M |
| Free Cash Flow Yield | -5.85% |